SCHEMBL14796604

SCHEMBL14796604

NC(=O)C(N)Cc1ccccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRA P18433 1/20 0.57
GRIN2D O15399 1/20 0.54
GRIN3B O60391 1/20 0.54
GRIN1 Q05586 1/20 0.54
GRIN2A Q12879 1/20 0.54
GRIN2B Q13224 1/20 0.54
GRIN2C Q14957 1/20 0.54
GRIN3A Q8TCU5 1/20 0.54
FDPS P14324 1/20 0.53
DPP4 P27487 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.47
PARP10 Q53GL7 1/20 0.46
CYP1A2 P05177 5/20 0.46
HRH1 P35367 1/20 0.44
LMNA P02545 1/20 0.44
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10250742 1.00 PTPRA (0.57) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL5270954 1.00 PTPRA (0.57) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL28583206 0.98 PTPRA (0.56) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL28583202 0.98 PTPRA (0.56) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL2713493 0.98 PTPRA (0.56) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL2713490 0.98 PTPRA (0.56) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL29401000 0.86 PTPRA (0.67) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL22409316 0.86 PTPRA (0.67) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL29805516 0.86 PTPRA (0.67) PTPRAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL126509 0.86 PTPRA (0.67) PTPRAGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3315492-B1 PYRAZOLE DERIVATIVE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL (JP) 2020-09-16 EP disclosed
EP-3176154-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS Portola Pharmaceuticals, Inc. (US) 2017-06-07 EP disclosed
EP-2573079-A2 Benzimidazole quinolinones and uses thereof Novartis Vaccines and Diagnostics, Inc. (US) 2013-03-27 EP disclosed
CN-1976706-B FGFR3 inhibition and treatment of multiple myeloma NOVARTIS VACCINES & DIAGNOSTIC 2012-01-18 CN disclosed
CN-1976706-A FGFR3 inhibition and treatment of multiple myeloma CHIRON CORP (US) 2007-06-06 CN disclosed
CN-1238779-A Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis ELAN PHARM INC (US) 1999-12-15 CN disclosed